Eagle Asset Management Inc Heron Therapeutics, Inc. Transaction History

Eagle Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 04, 2019	SELL	$16.36 - $21.39 $23.5 Million - $30.8 Million	-1,437,681 Closed	0 $0
Q2 2019 Aug 05, 2019	SELL	$16.93 - $26.22 $4.17 Million - $6.46 Million	-246,243 Reduced 14.62%	1,437,681 $26.7 Million
Q1 2019 May 01, 2019	SELL	$23.15 - $28.34 $42,295 - $51,777	-1,827 Reduced 0.11%	1,683,924 $41.2 Million
Q4 2018 Feb 11, 2019	SELL	$22.03 - $32.01 $1.18 Million - $1.72 Million	-53,679 Reduced 3.09%	1,685,751 $43.7 Million
Q3 2018 Nov 08, 2018	SELL	$30.0 - $40.85 $399,750 - $544,326	-13,325 Reduced 0.76%	1,739,430 $55.1 Million
Q2 2018 Aug 07, 2018	SELL	$26.4 - $42.0 $1.56 Million - $2.48 Million	-59,034 Reduced 3.26%	1,752,755 $68.1 Million
Q1 2018 May 09, 2018	BUY	$18.43 - $28.8 $33.4 Million - $52.2 Million	1,811,789 New	1,811,789 $50 Million

173

114M

32.4K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $204M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Eagle Asset Management Inc with notifications on news.